Maze Therapeutics (MAZE) Other Working Capital Changes (2024 - 2026)
Maze Therapeutics (MAZE) reported Other Working Capital Changes of $18000.0 for Q1 2026, up 102.24% on a YoY basis from $8900.5 in Q1 2025, and down 99.27% sequentially from $2.5 million in Q4 2025.
Maze Therapeutics (MAZE) Other Working Capital Changes (2024 - 2026) Analysis & Trends
Maze Therapeutics (MAZE) has 3 years of Other Working Capital Changes data on file, last reported at $18000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 102.24% year-over-year to $18000.0; the trailing twelve-month figure through Mar 2026 stood at $844000.0 (up 372.26% YoY), and the FY2025 full-year result was $21000.0, down 96.36% from the prior year.
- Other Working Capital Changes retreated to $18000.0 in Q1 2026, from $2.5 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $3.3 million in Q4 2025 to a low of -$2.1 million in Q3 2025.
- A 3-year average of $537888.9 and a median of $474000.0 in 2025 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 1170.77% in 2025, while the deepest fall reached 1081.71% in 2025.
- Tracing MAZE's Other Working Capital Changes over 3 years: stood at $2.7 million in 2024, then slipped by 8.94% to $2.5 million in 2025, then slumped by 99.27% to $18000.0 in 2026.
- Business Quant data shows MAZE's Other Working Capital Changes at $18000.0 in Q1 2026, $2.5 million in Q4 2025, and -$2.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Maze Therapeutics | 1.49 Bn | 1.49 Bn | 18.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18,000.00 |
| Mar 31, 2026 | 18,000.00 |
| Mar 31, 2026 | 18,000.00 |
| Dec 31, 2025 | 2.47 Mn |
| Dec 31, 2025 | 2.47 Mn |
| Dec 31, 2025 | 2.47 Mn |
| Sep 30, 2025 | -2.47 Mn |
| Sep 30, 2025 | -2.47 Mn |
| Sep 30, 2025 | -2.47 Mn |
| Jun 30, 2025 | 826,000.00 |
| Jun 30, 2025 | 826,000.00 |
| Jun 30, 2025 | 826,000.00 |
| Mar 31, 2025 | -805,000.00 |
| Mar 31, 2025 | -805,000.00 |
| Mar 31, 2025 | -805,000.00 |
| Dec 31, 2024 | 2.71 Mn |
| Dec 31, 2024 | 2.71 Mn |
| Dec 31, 2024 | 2.71 Mn |
| Sep 30, 2024 | -2.28 Mn |
| Sep 30, 2024 | -2.28 Mn |